SARM1 detection in myelinating glia:

SARM1 Schwann cell mouse myelination oligodendrocyte zebrafish

Journal

Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935

Informations de publication

Date de publication:
2023
Historique:
received: 03 02 2023
accepted: 14 03 2023
medline: 24 4 2023
pubmed: 24 4 2023
entrez: 24 04 2023
Statut: epublish

Résumé

Since SARM1 mutations have been identified in human neurological disease, SARM1 inhibition has become an attractive therapeutic strategy to preserve axons in a variety of disorders of the peripheral (PNS) and central nervous system (CNS). While SARM1 has been extensively studied in neurons, it remains unknown whether SARM1 is present and functional in myelinating glia? This is an important question to address. Firstly, to identify whether SARM1 dysfunction in other cell types in the nervous system may contribute to neuropathology in SARM1 dependent diseases? Secondly, to ascertain whether therapies altering SARM1 function may have unintended deleterious impacts on PNS or CNS myelination? Surprisingly, we find that oligodendrocytes express

Identifiants

pubmed: 37091921
doi: 10.3389/fncel.2023.1158388
pmc: PMC10113485
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1158388

Subventions

Organisme : Wellcome Trust
ID : 206634/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 210904/Z/18/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2023 Fazal, Mutschler, Chen, Turmaine, Chen, Hsueh, Ibañez-Grau, Loreto, Casillas-Bajo, Cabedo, Franklin, Barker, Monk, Steventon, Coleman, Gomez-Sanchez and Arthur-Farraj.

Déclaration de conflit d'intérêts

MC was a consultant for Nura Bio. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nature. 2015 Jan 29;517(7536):612-5
pubmed: 25470057
J Exp Med. 2007 Sep 3;204(9):2063-74
pubmed: 17724133
Hum Mol Genet. 2014 Apr 15;23(8):2220-31
pubmed: 24256812
Bioinformatics. 2009 Jun 1;25(11):1463-5
pubmed: 19346324
Nat Rev Neurosci. 2020 Apr;21(4):183-196
pubmed: 32152523
Development. 2011 Oct;138(20):4443-50
pubmed: 21880787
Acta Neuropathol Commun. 2017 Jun 23;5(1):50
pubmed: 28645311
Cell Rep. 2020 Apr 7;31(1):107498
pubmed: 32268088
Exp Neurol. 2019 Oct;320:112958
pubmed: 31132363
Future Virol. 2008;3(6):579-593
pubmed: 19079794
J Cell Biol. 2015 Jul 6;210(1):153-68
pubmed: 26150392
Mol Neurodegener. 2022 Jan 6;17(1):1
pubmed: 34991663
JCI Insight. 2019 Sep 5;4(17):
pubmed: 31484833
Cell Rep. 2021 Oct 19;37(3):109872
pubmed: 34686345
Science. 2012 Jul 27;337(6093):481-4
pubmed: 22678360
Nature. 2013 Apr 25;496(7446):494-7
pubmed: 23594742
J Cell Biol. 2011 May 16;193(4):769-84
pubmed: 21555464
Nat Neurosci. 2010 Jan;13(1):133-40
pubmed: 20023653
Development. 2018 Jun 26;145(12):
pubmed: 29945988
Brain. 2016 Apr;139(Pt 4):1094-105
pubmed: 26912636
Dev Dyn. 2007 Nov;236(11):3088-99
pubmed: 17937395
Exp Neurol. 2019 Nov;321:113040
pubmed: 31445042
N Engl J Med. 1980 Jan 10;302(2):73-7
pubmed: 6243167
Glia. 2011 May;59(5):720-33
pubmed: 21322058
J Neurosci. 2013 Aug 14;33(33):13569-80
pubmed: 23946415
Commun Biol. 2020 Jan 30;3(1):49
pubmed: 32001778
Nature. 2005 Jul 21;436(7049):347-55
pubmed: 16034409
Methods Cell Biol. 2017;138:383-414
pubmed: 28129853
Cell Rep. 2021 Dec 14;37(11):110108
pubmed: 34910914
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Exp Neurol. 2021 Apr;338:113607
pubmed: 33460644
Exp Neurol. 2021 May;339:113636
pubmed: 33548217
Brain. 2016 Dec;139(Pt 12):3092-3108
pubmed: 27797810
Nat Genet. 2016 Sep;48(9):1043-8
pubmed: 27455348
Elife. 2020 Oct 27;9:
pubmed: 33107823
Nat Rev Neurosci. 2005 Sep;6(9):671-82
pubmed: 16136171
Neurotherapeutics. 2021 Oct;18(4):2200-2221
pubmed: 34595734
Front Mol Neurosci. 2022 Apr 13;15:860410
pubmed: 35493328
Mol Cell Neurosci. 2003 Apr;22(4):430-40
pubmed: 12727441
Elife. 2021 Dec 06;10:
pubmed: 34870595
Diabetes. 2019 Nov;68(11):2120-2130
pubmed: 31439642
Trends Pharmacol Sci. 2020 Apr;41(4):281-293
pubmed: 32107050
BMC Bioinformatics. 2012 Jun 18;13:134
pubmed: 22708584
J Peripher Nerv Syst. 2017 Sep;22(3):162-171
pubmed: 28485482
Innate Immun. 2014 Feb;20(2):161-72
pubmed: 23751821
Elife. 2021 Nov 19;10:
pubmed: 34796871
Cell Death Dis. 2022 Sep 2;13(9):759
pubmed: 36055989
PLoS Biol. 2010 Jan 26;8(1):e1000300
pubmed: 20126265
PLoS One. 2011;6(11):e27146
pubmed: 22073277
Trends Neurosci. 2022 Jan;45(1):53-63
pubmed: 34852932
Cell Rep. 2017 Sep 12;20(11):2719-2734
pubmed: 28903050
J Exp Med. 2019 Apr 1;216(4):743-756
pubmed: 30842236
J Exp Med. 2019 Feb 4;216(2):294-303
pubmed: 30642945
Theranostics. 2021 Feb 20;11(9):4187-4206
pubmed: 33754056
Exp Neurol. 2019 Oct;320:112961
pubmed: 31136762
Brain. 2021 Nov 29;144(10):3226-3238
pubmed: 33964142
J Cell Biol. 2020 Aug 3;219(8):
pubmed: 32609299

Auteurs

Shaline V Fazal (SV)

Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom.
Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Clara Mutschler (C)

Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom.

Civia Z Chen (CZ)

Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Mark Turmaine (M)

Department of Cell and Developmental Biology, University College London, London, United Kingdom.

Chiung-Ya Chen (CY)

Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.

Yi-Ping Hsueh (YP)

Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.

Andrea Ibañez-Grau (A)

Instituto de Neurociencias de Alicante, Universidad Miguel Hernández, Alicante, Spain.

Andrea Loreto (A)

Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom.

Angeles Casillas-Bajo (A)

Instituto de Neurociencias de Alicante, Universidad Miguel Hernández, Alicante, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.

Hugo Cabedo (H)

Instituto de Neurociencias de Alicante, Universidad Miguel Hernández, Alicante, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.

Robin J M Franklin (RJM)

Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
Altos Labs - Cambridge Institute of Science, Cambridge, United Kingdom.

Roger A Barker (RA)

Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom.
Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Kelly R Monk (KR)

Vollum Institute, Oregon Health & Science University, Portland, OR, United States.

Benjamin J Steventon (BJ)

Department of Genetics, University of Cambridge, Cambridge, United Kingdom.

Michael P Coleman (MP)

Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom.

Jose A Gomez-Sanchez (JA)

Instituto de Neurociencias de Alicante, Universidad Miguel Hernández, Alicante, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Millennium Nucleus for the Study of Pain (MiNuSPain), Santiago, Chile.

Peter Arthur-Farraj (P)

Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom.

Classifications MeSH